The Weight-Loss Drug Market Heats Up The battle for the booming obesity drug market just took a dramatic turn. On March 5, 2025, Danish pharmaceutical giant Novo Nordisk announced a price reduction for its blockbuster weight-loss drug Wegovy—offering it at $499 per month for uninsured patients and those without insurance coverage for obesity medication. This […]
